Merck & Co., Inc.
Merck & Co., Inc.
Categories
Biotech Pharmaceutical
About
Merck & Co., Inc. is a healthcare company that specializes in innovative medicines, vaccines, biologic therapies, consumer health and animal products.
Industry News & Announcements
- Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline
- FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)
- Merck Completes Acquisition of Harpoon Therapeutics, Inc.
- Merck to Buy Elanco’s Aqua Business for $1.3 Billion
- Merck to Buy Harpoon Therapeutics for $680 Million
- FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor
- Merck to Acquire Caraway Therapeutics, Inc.
- AZ, Merck's Lynparza wins FDA nod in prostate cancer subgroup following advisory committee vote
Powered By GrowthZone
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.